You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The assay is the twelfth to be granted Emergency Use Authorization by the US Food and Drug Administration for Ebola testing.
A temporary sequencing facility in Sierra Leone that was used to sequence Ebola has been moved to a new infectious disease laboratory at the University of Makeni.
Ebola virus genomes from a post-epidemic flare-up last June showed relatively low genetic divergence compared with related strains from the broader outbreak.
The South Korean company said the kit not only detects Zika, but is also set up to find multiple mosquito-borne diseases such as Dengue and Chikunguya.
The firm has improved design of the system for low-resource settings and validated it on clinical chlamydia samples and extracted HIV, Ebola, and dengue samples.
In Nature this week: genomic surveillance of Ebola, bed bug genome, and more.
Genome sequences for more than 100 Ebola virus isolates from Guinea uncovered two main lineages that caused infections in the country in 2015.
The researchers are using an NIH grant to develop a device to discriminate various fever-causing viruses endemic to West Africa and Plasmodium falciparum.
Using new and existing Ebola virus genomes, researchers retraced transmission events involved in the second wave of infections in Liberia.
A study of samples from Sierra Leone and the UK of heat-inactivated whole blood showed high sensitivity and specificity using the FilmArray BioThreat-E test.
Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.
Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.
Stat News reports some health tech startups are laying off or furloughing workers.
In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.